Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints. [electronic resource]
Producer: 20120127Description: 3702-11 p. digitalISSN:- 1529-0131
- Adalimumab
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Arthrography
- Disease Progression
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Humans
- Infliximab
- Joints -- pathology
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Outcome Assessment, Health Care -- methods
- Remission Induction
- Retrospective Studies
- Severity of Illness Index
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.